Key result
A velocity half-time of diastolic flow velocity <9.5 distinguished constrictive pericarditis from restrictive cardiomyopathy with 86% sensitivity and 88% specificity.
Why the study?
Do phasic coronary flow characteristics differ between patients with constrictive pericarditis and restrictive cardiomyopathy?
Case-Control (n=26)
Do phasic coronary flow characteristics differ between patients with constrictive pericarditis and restrictive cardiomyopathy?
Absolute Event Rate: 6.2% vs 10.6%
p-value: p=<.001
Phasic coronary flow characteristics, specifically rapid acceleration and deceleration of diastolic flow velocity, can help distinguish constrictive pericarditis from restrictive cardiomyopathy.
May aid noninvasive differentiation in suspected cases; hypothesis-generating and requires prospective validation before changing practice.
BACKGROUND: Phasic coronary flow characteristics have been reported in patients with aortic valve disease and hypertrophic cardiomyopathy. The purpose of this study was to assess the differences in coronary flow characteristics between patients with constrictive pericarditis and those with restrictive cardiomyopathy. METHODS AND RESULTS: The study populations consisted of 7 case patients with constrictive pericarditis, 8 with restrictive cardiomyopathy, and 11 control subjects with chest pain and normal coronary arteries. Five minutes after injection of 3 mg of isosorbide dinitrate, phasic coronary flow velocity patterns were analyzed in the proximal segment of the angiographically normal left anterior descending coronary artery at rest using a 0.014-in, 15-MHz Doppler guidewire. Coronary flow reserve was obtained from the ratio of adenosine-induced (0.14 mg x kg(-1) x min(-1) I.V.) hyperemic/baseline time-averaged peak velocity. Although in case patients with constrictive pericarditis and restrictive cardiomyopathy maximal hyperemic time-averaged peak velocity (21+/-8 and 31+/-17 versus 60+/-19 cm/s, respectively; P<.001) and coronary flow reserve (1.3+/-0.4 and 1.6+/-0.6 versus 3.6+/-0.4, respectively, P<.001) were significantly lower than in control subjects, there were no significant differences in these indexes between the two groups of case patients. Velocity half-time of diastolic flow velocity corrected by square root(RR), which indicates deceleration of diastolic flow, in the groups of case patients with constrictive pericarditis and restrictive cardiomyopathy was significantly less than that in control subjects (6.2+/-2.6 and 10.6+/-1.5 versus 16.9+/-2.7, respectively; P<.001); this was also significantly smaller in constrictive pericarditis than restrictive cardiomyopathy (P<.001). This index <9.5 could distinguish constrictive pericarditis from restrictive cardiomyopathy with a sensitivity of 86% and a specificity of 88%. Furthermore, time from the beginning of diastole to diastolic peak velocity corrected by square root(RR) indicating acceleration of diastolic flow velocity in constrictive pericarditis was significantly less than that in restrictive cardiomyopathy and control subjects (2.8+/-1.2 versus 4.8+/-0.8 and 4.4+/-0.6, respectively; P<.001). CONCLUSIONS: Although coronary flow reserve is limited in both constrictive pericarditis and restrictive cardiomyopathy because of restriction of hyperemic response, rapid acceleration and more rapid deceleration of diastolic flow velocity are more characteristic in constrictive pericarditis than in restrictive cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Akasaka et al. (1997) conducted a case-control in Constrictive pericarditis and restrictive cardiomyopathy (n=26). Constrictive pericarditis vs. Restrictive cardiomyopathy was evaluated on Velocity half-time of diastolic flow velocity corrected by square root(RR) (p=<.001). A velocity half-time of diastolic flow velocity <9.5 distinguished constrictive pericarditis from restrictive cardiomyopathy with 86% sensitivity and 88% specificity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: